Recent study found that sex differences in microglial activation exist in themodulation of energy homeostasis and identified CX3CR1 signaling as a potential therapeutictarget for the treatment of metabolic diseases in mice such as obesity19. Here, CX3CR1 is linked to metabolic disease.